Oklo Advances Nuclear Tech with $288M War Chest but Burns $37M in 9 Months; Targets 2027 for First Reactor

SEC Track
2024-11-15

Core Highlights: - No revenue as the company is pre-revenue stage - Cash position strengthened significantly to $288.5 million after the SPAC merger in May 2024 - Operating expenses of $37.4 million for 9 months, mainly R&D and G&A costs
Revenue Breakdown: - No revenue yet as the Aurora powerhouse product line is still being developed - Plans to commercialize liquid metal fast reactor technology, with first 15-50 MWe Aurora plant targeted for 2027 deployment
Management Outlook: - Expects cash runway to fund operations for at least 12 months based on current cash - Key milestones include securing site permit, fuel award for Idaho plant - Focused on developing and deploying first commercial advanced fission power plant
Operating Data: - Operating expenses of $37.4M for 9 months, $24.9M cash used in operations - Raised $10.2M from SAFEs, $25M right of first refusal liability recorded - Under current loss rate, cash can support operations for over 7 quarters
Operational Risks: - Pursuing emerging market with no operating commercial project yet - Faces regulatory uncertainties, needs financing to construct plants - Risks from competition, market conditions, proposed Atomic Alchemy acquisition

Original Filing

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10